📰 Total Sharp Score News
Total Sharp Score News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Total Sharp Score. Real-time updates on events, politics, business and more.
November 18, 2023
In these phase 3 findings presented at ACR 2023, the safety and efficacy of this drug was proven in American College of Rheumatology-20 (ACR20), ACR50, and Disease Activity Score in 28 joints with Erythrocyte Sedimentation Rate responses.
December 15, 2022
A moderate agreement was noted between DAPSA and VLDA/MDA composite instruments among patients with PsA receiving tofacitinib.
May 23, 2022
First presentations from the BE OPTIMAL and BE COMPLETE studies evaluating bimekizumab in the treatment of adults with active psoriatic arthritis who were...
December 16, 2021
The FDA has approved Rinvoq (upadacitinib) for the treatment of active psoriatic arthritis.
December 14, 2021
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib; 15 mg, once daily) for...
December 14, 2021
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib; 15 mg, once daily) for...